Clinical HIV Management

Clinical HIV Management

Introduction to Clinical HIV and the Initial Evaluation

  • Describe the global epidemiology of HIV and its history.
  • Conduct an initial history and physical of a newly diagnosed HIV-infected patient.
  • Stage patients’ HIV disease severity based on both CDC and WHO HIV classifications.
  • Explain the challenges of delivering HIV care in resource-limited settings and the current strategies for meeting these challenges.

HIV Testing and Prevention

  • Answer the question “Who needs an HIV test”: Describe strategies for testing and testing requirements for different populations.
  • Outline the strategies to reduce secondary HIV transmission, starting with the infected patient.
  • Recognize the indications for post-exposure prophylaxis for both occupational and sexual HIV exposures and review PEP delivery.
  • Describe the role of pre-exposure prophylaxis and identify the patients most likely to benefit from PrEP and review PrEP delivery.

Antiretroviral Therapy (ART)

  • Describe the goals of antiretroviral therapy
  • Discuss key considerations related to the timing of antiretroviral therapy initiation.
  • List the classes of antiretroviral drugs and identify their distinguishing features, including key drug-drug interactions and potential adverse effects.
  • Identify recommended first-line antiretroviral regimens, as well as the pros/cons of different regimens
  • Describe the adverse effects of antiretroviral agents, both common and severe

Treatment Failure

  • Discuss the most common underlying causes of treatment failure
  • Describe the evaluation and management of treatment failure, including how the approach may differ based on the availability of HIV resistance testing
  • Outline the most common HIV resistance mutations and their implications for selecting an appropriate treatment regimen
  • Summarize the epidemiology and significance of non-communicable diseases (NCDs) among PLHIV
  • Describe the benefits and current approaches to integrating NCD care into routine HIV services

Tuberculous (TB)

  • Describe the epidemiology of TB and the epidemiologic relationship between HIV and TB
  • Describe the pathogenesis of TB in PLHIV, clinical manifestations, and algorithms for screening and diagnosis
  • Explain the principles of TB treatment for PLHIV
  • Outline modalities for TB prevention among PLHIV
  • Explain LTBI diagnosis and treatment among PLHIV

Opportunistic Infectious (OI)

  • Describe the approach to diagnosis and management of OIs affecting the CNS
  • Review the clinical features, diagnosis, and management of common non-CNS OIs
  • Discuss the benefits of co-trimoxazole prophylaxis and the rationale for its expanded role in resource-limited settings
  • Describe the significance of IRIS, including key diagnostic and management principles

HIV-Associated Malignancies

  • Review the epidemiology and clinical features of both AIDS-defining and non-AIDS-defining HIV-associated malignancies
  • Describe key factors that influence cancer treatment outcomes among PLHIV

Dermatology

  • Identify common clinical presentations and themes in HIV-related skin disease
  • Recognize important drug hypersensitivity syndromes that may occur more commonly in PLHIV

Pediatric HIV

  • Contrast the natural history and manifestations of HIV in infants and children versus that in adults
  • Explain key principles in the diagnosis and management of HIV infection in infants and children
  • Discuss approaches to preventing mother-to-child HIV transmission (PMTCT), as well as the progress and challenges of PMTCT efforts globally
  • Describe the unique challenges, considerations, and strategies in the management of HIV in adolescents and how adolescents’ needs differ from those of pediatric or adult patients.

STIs

  • Describe how sexually transmitted infection (STI) syndromes can present in persons living with HIV and review STI etiologies.
  • Differentiate between the syndromic versus etiologic approach to management of STIs in HIV-infected patients.
  • Explain the significance of common psychosocial barriers experienced by PLHIV, including stigma.

Psychosocial

  • Discuss the role of behavioral and psychosocial support interventions for improving HIV outcomes.
  • Identify and describe the epidemiology of mental health conditions that are common among PLHIV.

Special Population

  • Appreciate the unique issues central to caring for an HIV-infected woman. (Women)
  • Describe key (high-risk) populations and understand their unique challenges and needs (CSW, MSM, Transgender, PWID)

PAYMENT AND REGISTRATION DETAILS

Company’s Account
1222030790
Zenith Bank
Ekundayo Educonsult for Healthcare Professionals.


Domiciliary Account
3184967233
First Bank of Nigeria
Mustapha Yusuf Ekundayo


For International Students
Any of the options below can also be used
– Western Union
– Money gram
– World Remit
– Mukuru, etc

Send proof of payment through our WhatsApp Chat Icon visible on every page

Clinical HIV Management

Register with Bank Transfer / other modes of Payment methods
Register with Card Online Payment Method

Clinical HIV Management: A Comprehensive Guide

Managing HIV effectively is critical to improving patient outcomes and controlling the global epidemic. Clinical HIV management involves a multidisciplinary approach that includes timely diagnosis, antiretroviral therapy (ART), patient education, and ongoing care to address complications and co-morbidities.

This guide provides healthcare professionals with insights into the latest HIV management strategies, best practices, and innovations in care delivery.

1. Understanding HIV: The Basics

1.1 What is HIV?

HIV (Human Immunodeficiency Virus) is a retrovirus that attacks the immune system, specifically the CD4 cells, leading to immunodeficiency and increased susceptibility to opportunistic infections.

1.2 Difference Between HIV and AIDS

  • HIV: Refers to the virus and its infection stage.
  • AIDS (Acquired Immunodeficiency Syndrome): The advanced stage of HIV infection, characterized by severe immune system damage.

1.3 Modes of Transmission

  • Unprotected sexual contact.
  • Sharing contaminated needles.
  • Mother-to-child transmission during pregnancy, childbirth, or breastfeeding.
  • Transfusion of contaminated blood.

2. Key Principles of Clinical HIV Management

2.1 Early Diagnosis

  • Routine testing, especially in high-risk populations.
  • Use of rapid diagnostic tests (RDTs) and confirmatory lab tests like ELISA and Western blot.

2.2 Initiating Antiretroviral Therapy (ART)

  • ART should be started as soon as possible after diagnosis, regardless of CD4 count.
  • First-line regimens typically include a combination of two nucleoside reverse transcriptase inhibitors (NRTIs) and one integrase strand transfer inhibitor (INSTI).

2.3 Monitoring and Follow-Up

  • Regular viral load testing to ensure viral suppression (<50 copies/mL).
  • CD4 count monitoring for immune recovery.
  • Screening for drug resistance and treatment adherence.

2.4 Addressing Co-Morbidities

  • Managing co-infections like tuberculosis (TB), hepatitis B/C, and sexually transmitted infections (STIs).
  • Screening and treating non-communicable diseases like diabetes, hypertension, and mental health disorders.

3. Antiretroviral Therapy (ART): Current Guidelines

3.1 Goals of ART

  • Suppress viral replication.
  • Restore and preserve immune function.
  • Reduce HIV-related morbidity and mortality.
  • Prevent HIV transmission.

3.2 Types of Antiretroviral Drugs

  1. Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs):
    • Examples: Tenofovir, Lamivudine, Emtricitabine.
  2. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs):
    • Examples: Efavirenz, Rilpivirine.
  3. Protease Inhibitors (PIs):
    • Examples: Lopinavir, Ritonavir.
  4. Integrase Strand Transfer Inhibitors (INSTIs):
    • Examples: Dolutegravir, Raltegravir.
  5. Entry and Fusion Inhibitors:
    • Examples: Enfuvirtide, Maraviroc.

3.3 Side Effects and Management

  • Common side effects include nausea, fatigue, and headache.
  • Long-term complications may include renal dysfunction, bone density loss, and cardiovascular risks.

4. Special Considerations in HIV Management

4.1 Managing HIV in Pregnant Women

  • Preventing mother-to-child transmission (PMTCT) through ART during pregnancy and delivery.
  • Neonatal prophylaxis and breastfeeding counseling.

4.2 Pediatric HIV Management

  • Pediatric ART regimens tailored to age and weight.
  • Addressing growth and developmental delays.

4.3 HIV and Aging

  • Older adults with HIV require care for age-related conditions like osteoporosis and cognitive decline.

5. Innovations in HIV Management

5.1 Long-Acting Antiretroviral Drugs

  • Injectable ART regimens that reduce dosing frequency.

5.2 Pre-Exposure Prophylaxis (PrEP)

  • Daily or on-demand medication for HIV prevention in high-risk populations.

5.3 Advances in Diagnostics

  • Point-of-care testing and self-testing kits for faster diagnosis.

5.4 Digital Health Tools

  • Mobile apps for ART adherence monitoring and patient education.

6. Addressing Social and Psychological Aspects

6.1 Reducing Stigma

  • Community awareness programs to combat HIV-related stigma.

6.2 Supporting Mental Health

  • Counseling services for patients dealing with anxiety, depression, or disclosure challenges.

6.3 Empowering Patients

  • Education on HIV transmission prevention and the importance of adherence to ART.

7. The Role of Healthcare Providers in HIV Management

7.1 Multidisciplinary Care Teams

  • Collaboration among physicians, nurses, pharmacists, social workers, and counselors.

7.2 Continuous Professional Development

  • Ongoing training in the latest HIV treatment guidelines and research.

7.3 Advocacy and Policy Engagement

  • Advocating for affordable ART and equitable healthcare access.

8. Challenges in HIV Management

8.1 Drug Resistance

  • Managing cases of treatment failure due to resistance mutations.

8.2 Healthcare Access Barriers

  • Addressing gaps in rural and underserved areas.

8.3 Retention in Care

  • Strategies to reduce patient loss to follow-up.

Conclusion

Clinical HIV management is a dynamic and critical field in healthcare. By adhering to the latest treatment guidelines, leveraging innovations, and addressing the holistic needs of patients, healthcare providers can significantly improve outcomes for individuals living with HIV.

Ekundayo Educonsult offers specialized training programs for healthcare professionals in HIV management, equipping them with the knowledge and skills to excel in this vital area.

Take the step toward becoming a leader in HIV care—enroll in our courses today!